Skip to main content
OpenTrials
Completed

NCT Number: NCT00432159

Comparison of DISCOVER™ Artificial Cervical Disc and ACDF for Treatment of Cervical DDD (IDE Study)

This study is intended to treat patients with symptomatic degenerative disc disease at one level of the cervical spine. The patients will be randomized to the DISCOVER Artificial Cervical Disc (total disc replacement) or SLIM-LOC™ (cervical fusion) to determine the safety and efficacy at 2 years post operative. Follow-up on patients treated with total disc replacement will be continued to 5 years post operative.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cervical Degenerative Disc Disease

Age range

21 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pacific Private Clinic, Queensland, Australia

Loading trial locations.

About this study

This study is designed as a multicenter, prospective, randomized, controlled trial. Subjects will be stratified by the number of levels to be treated then assigned treatment in a randomized 1:1 ratio. Participants in the treatment group will undergo cervical total disc replacement with the DISCOVER Artificial Cervical Disc. Participants in the control group will undergo anterior cervical discectomy and fusion with the SLIM-LOC™ Anterior Cervical Plate System with a cortical or cortico-cancellous allograft spacer. Follow-up visits will occur at 2 weeks, 3 and 6 months and 1, and 2 years for all randomized subjects. Subjects that received the control treatment will complete their required study participation at 2 years post operative and subjects assigned the Discover treatment will complete their participation at 5 years post operative. Follow-up for the Discover treatment group will be via a telephone administered questionnaire at 3, 4 and 5 years post operative.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Key Inclusion Criteria:

  • Objective evidence of cervical disc disease in 1 vertebral level between C3-C7 defined as (a) shoulder and/or arm pain in a documented radicular distribution resulting from herniated disc or bony osteophytes or (b)myeloradiculopathy resulting from mild spinal cord compression and nerve root impingement
  • Unresponsiveness to documented non-surgical management for greater than or equal to 6 weeks and/or presentation with progressive symptoms of nerve root or spinal cord compression in the face of continued non-surgical management
  • Moderate Neck Disability Index (NDI) score
  • Able to give informed consent for study participation
  • Able and willing to return for all follow-up visits

Key Exclusion Criteria:

  • Significant cervical degenerative disc disease
  • Prior fusion procedure at any level(s) (C1-T1)
  • Marked cervical instability on lateral or flexion/extension radiographs
  • Presence of systemic infection or infection at the surgical site
  • Diagnosis of a condition, or requires postoperative medication(s), which may interfere with bony/soft tissue healing
  • History of alcohol and/or drug abuse
  • Any known allergy to a metal alloy or polyethylene
  • Morbid obesity
  • Any significant general illness (e.g., metastatic cancer, HIV)

Treatment and study plan

Cervical TDR

Device

Cervical total disc replacement using a DISCOVER Artificial Cervical Disc.

Other names: cervical arthroplasty, cervical disc, c-TDR, DISCOVER disc

ACDF with plate

Device

Anterior cervical discectomy followed by insertion of allograft spacer and placement of an anterior plate.

Other names: ACDF, Slim-Loc, Anterior cervical discectomy and fusion with plate

Primary outcomes

  1. Overall Success

    Time frame: 24 months

    Subject must show 15 point improvement in the Neck Disability Index from baseline to 24 months post operative as well as have no device related SAE, Secondary Surgical Interventions at the index level or any new permanent neurological deterioration.

Secondary outcomes

  1. NDI Success

    Time frame: 24 months

    15 point improvement in NDI. NDI has a max score of 50, which is calculated based on the 6 answers to each of the 10 questions. Each answer within a question is given a numerical value 0 to 5.

  2. Neurological Component of Success

    Time frame: 24 months

    no new clinically significant permanent abnormalities in neurological function

  3. Subsequent Secondary Surgery Component of Success

    Time frame: 24 months

    no subsequent secondary surgical intervention at the index level

  4. Device-Related SAE Component of Success

    Time frame: 24 months

    no device related serious adverse events

  5. NDI - Change From Baseline

    Time frame: 24 months

    Change from baseline of the Neck Disability Index. NDI has a minimum score of 0 (no disability) and a maximum score of 50 (complete disability) , which is calculated based on the 6 answers to each of the 10 questions. Each answer within a question is given a numerical value 0 to 5.

  6. Neck Pain VAS Scores - Change From Baseline

    Time frame: 24 months

    Change from baseline of the Neck Pain VAS Scores. VAS is a 100-mm visual analog scale used to assess pain. It asks the subject to place a vertical mark on a 100-mm horizontal line, with 'No pain' listed on the left (at 0 mm) and 'Very severe pain' labeled on the right (at 100 mm). The subject is instructed to indicate the amount of pain they feel in their neck.

  7. Maximum Arm Pain VAS - Change From Baseline

    Time frame: 24 months

    Change from baseline in maximum value of the left and right arm VAS scores. VAS is a 100-mm visual analog scale used to assess pain. It asks the subject to place a vertical mark on a 100-mm horizontal line, with 'No pain' listed on the left (at 0 mm) and 'Very severe pain' labeled on the right (at 100 mm). The subject is instructed to indicate the amount of pain they feel in their arm.

  8. Average Arm Pain VAS - Change From Baseline

    Time frame: 24 months

    Change from baseline in average of the left and right arm VAS scores. VAS is a 100-mm visual analog scale used to assess pain. It asks the subject to place a vertical mark on a 100-mm horizontal line, with 'No pain' listed on the left (at 0 mm) and 'Very severe pain' labeled on the right (at 100 mm). The subject is instructed to indicate the amount of pain they feel in their arm.

  9. Maximum Shoulder Pain VAS - Change From Baseline

    Time frame: 24 months

    Change from baseline in Maximum value of the left and right shoulder VAS scores. VAS is a 100-mm visual analog scale used to assess pain. It asks the subject to place a vertical mark on a 100-mm horizontal line, with 'No pain' listed on the left (at 0 mm) and 'Very severe pain' labeled on the right (at 100 mm). The subject is instructed to indicate the amount of pain they feel in their shoulder.

  10. Average Shoulder Pain VAS - Change From Baseline

    Time frame: 24 months

    Change from baseline in Average of the left and right shoulder VAS scores. VAS is a 100-mm visual analog scale used to assess pain. It asks the subject to place a vertical mark on a 100-mm horizontal line, with 'No pain' listed on the left (at 0 mm) and 'Very severe pain' labeled on the right (at 100 mm). The subject is instructed to indicate the amount of pain they feel in their shoulder.

  11. Dysphagia Disability Index - Change From Baseline

    Time frame: 24 months

    Change from baseline in Dysphagia Disability Index (DDI). The DDI is designed to evaluate dysphagia, difficulty in swallowing, using a 25-item questionnaire. Responses from the questionnaire were scored as "always" 4, "sometimes" 2, or "never" 0, and summed to provide a total score (range 0-100). Higher DDI scores suggest greater subjective signs of dysphagia.

  12. SF-36 - Physical Composite Scores (PCS) - Change From Baseline

    Time frame: 24 months

    Change from baseline in Quality of Life - Physical Composite Scores. SF-36 is based on units on a scale; where 0 is severe disability and 100 is no disability. The scores are scaled (based on weighted sum of the questions)

  13. SF-36 - Mental Composite Scores (MCS) - Change From Baseline

    Time frame: 24 months

    Change from baseline in Quality of Life - Mental Composite Scores. SF-36 is based on units on a scale; where 0 is severe disability and 100 is no disability. The scores are scaled (based on weighted sum of the questions)

  14. Work Status Assessment

    Time frame: 24 months

  15. Return to Work

    Time frame: 24 months

    Estimated Proportion of Subjects Returning to Work

  16. Activity

    Time frame: 24 months

    Clinical Assessment of Activity

  17. Subject Satisfaction

    Time frame: 24 months

    Subject Satisfaction (Would you have this procedure again?)

  18. Global Cervical Range of Motion - Change From Baseline

    Time frame: 24 months

  19. Average Radiographic Disc Height (mm) - Change From Post-op

    Time frame: 24 months

Sponsors and collaborators

Lead sponsor

DePuy Spine

Industry

Registry information

Official study title

A Multi-Center, Prospective, Randomized Controlled Trial Comparing Cervical Arthroplasty to Anterior Cervical Discectomy and Fusion for the Treatment of Cervical Degenerative Disc Disease

Important dates

Study start
2006
Primary completion
2013
Study completion
2016
First posted
Feb 7, 2007
Registry last updated
Oct 20, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.